PORT WASHINGTON, NY – Aceto announced the acquisition of Syntor Fine Chemicals. Syntor is an asset-light manufacturer of fine chemicals for pharmaceutical and other life sciences end markets.
“The acquisition of Syntor is an important step in Aceto’s strategic growth plan,” said Gilles Cottier, Chief Executive Officer of Aceto. “Syntor’s synthesis and formulation capabilities enhance Aceto’s existing services and expand our value-added offerings in life sciences materials. With the addition of Syntor’s technical team, we can provide greater product customization in addition to supplying our current offering of high-quality, specialty materials.”